Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach
Year: 2016
Type: review
Study design: Systematic Review
Abstract: OBJECTIVES: Our study aimed to determine whether data obtained from the medical literature can be used to estimate the therapeutic index of 5 antiepileptic drugs (AEDs): carbamazepine, lamotrigine, phenobarbital, phenytoin, and valproate. METHODS: We performed a literature search using PubMed and EMBASE to collect published safety, efficacy, and therapeutic monitoring data for 5 AEDs and extracted all relevant information into a drug- and study-specific drug database. For each AED, we summarized (1) type, severity, and incidence of toxicity-related adverse events and toxicity-associated range of drug doses or concentrations; (2) effective versus toxic concentration and dose (therapeutic range); and (3) therapeutic drug monitoring practices. We defined therapeutic index as the ratio of the minimum toxic concentration to the minimum effective concentration. RESULTS: We reviewed a total of 810 full-text articles and extracted data from 163. The literature suggests that the therapeutic index of phenytoin is 2. The therapeutic indices of phenobarbital and valproate exceed 2. There were insufficient data to precisely quantify the therapeutic indices of carbamazepine and lamotrigine. CONCLUSIONS: For some drugs, this approach offers a low-cost method of therapeutic index estimation. Our results can serve as preliminary data for future trials and as guidance for US Food and Drug Administration decision making regarding narrow therapeutic index classification.
Source: Clinical Neuropharmacology
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: National Institutes of Health, U.S. Food and Drug Administration, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: Duke Research Training Program for Pediatricians, G1102705159, G1468556634, Use of Physiologically-Based PK/PD Models to Streamline Drug Approvals, Duke CTSA (Composite), G2829770695, G3008453, G5139652136, Physiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children, Immunological biomarker studies in myasthenia gravis, Multidisciplinary Neonatal Training Grant, Center for Molecular & Cellular Studies of Ped Disease, G7378573625
OpenAlex ID: W2470709485
